InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Hanna, John Gordon. Director active across 1 company, notably HLS Therapeutics Inc.. Cumulatively, 3 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €11k. History available since 16 June 2026. The latest transaction was filed on 26 June 2026 (56 - Grant of rights). Regulator: SEDI. All data is openly available.
3 of 3 declarations
John Gordon Hanna is a declarant linked to HLS Therapeutics Inc. (XTSE), where he is listed as 4 - Director of Issuer, 5 - Senior Officer of Issuer. His record shows 3 filings in total, and across the 3 sampled recent filings from 2026-06-17 to 2026-06-30, the buy amount is EUR 10592 with no reported sales; the most common transaction nature is 56 - Grant of rights.